Silence Therapeutics plc
divesiran
polycythemia vera
Resolved
26days ago
Phase 1 readout · ~ Jun 11, 2026 estimated
What's at stake
Phase 1 trial results for divesiran in polycythemia vera are due ~ Jun 11, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 15h ago
“SANRECO Phase 1 Study OverviewCompleted in February 2025”